MTRC has released technical overviews of reimbursement processes in Austria, Russia and Switzerland

On January 14, 2022, the Government of the Russian Federation released a Decree which approved the inclusion of three devices (implantable pulse generator for urinary/fecal incontinence, bioprosthetic aortic valve/xenoprosthesis, and vessels embolization material) in the List of Essential Implantable Medical Devices.

In December 2021, nineteen clinical guidelines relating to cardiovascular, gastrointestinal, men’s health, peripheral vascular, and other disease areas were released in Russia.

On December 20, 2021, the tariff partners of the novel TARDOC reimbursement system for outpatient care (association of health insurers curafutura and association of physicians, FMH) re-submitted the substantially revised version 1.3 of TARDOC to the Federal Council. The tariff partners hope that the Federal Council will assess the new reimbursement system in the first quarter of 2022 and that it could be implemented from January 2023.

In November 2021, twelve clinical guidelines, relating to gastrointestinal, ENT, orthopedic, and other disease areas, were released in Russia.

On December 06, 2021, the President of the Russian Federation signed the Federal Law on a budget of mandatory Health Insurance for 2022 and the planning period of 2023 and 2024. In accordance with the approved budget, the amount of High-end Medical Care outside the basic compulsory medical insurance program for federal clinics will be 109.9 billion RUB which is an increase of 2.7 billion RUB.